Business Description
Bumrungrad Hospital PCL
ISIN : TH0168A10Z19
Share Class Description:
FRA:BZ7A: Shs Foreign RegisteredCompare
Compare
Traded in other countries / regions
BH.ThailandBZ7A.GermanyBUGDF.USA IPO Date
2009-09-08Description
Bumrungrad Hospital PCL operates a private hospital business in Bangkok. The company operates several healthcare-related entities, within and outside of Thailand which include Bumrungrad International Hospital, Bumrungrad International Clinic, Vitallife Scientific Wellness Center, VitalLife Skin Clinic, Bumrungrad International Dialysis Clinic, and others. It is a healthcare provider in Thailand providing complete healthcare services for both outpatients and inpatients. The company is the owner and operator of multiple healthcare-related entities. The company has only one main reportable operating segment, which is the hospital and health care center business, and the geographical area of its operations is Thailand.
Financial Strength
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 75.93 | |||||
Equity-to-Asset | 0.83 | |||||
Debt-to-EBITDA | 0.01 | |||||
Interest Coverage | 1792.01 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | 20.33 | |||||
Beneish M-Score | -1.9 | |||||
WACC vs ROIC | ||||||
Growth Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 6.8 | |||||
3-Year EBITDA Growth Rate | 13.1 | |||||
3-Year EPS without NRI Growth Rate | 15.1 | |||||
3-Year FCF Growth Rate | 7.2 | |||||
3-Year Book Growth Rate | 16.1 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate Industry Rank | 4.81 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 5.27 |
Momentum Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 74.88 | |||||
9-Day RSI | 67.95 | |||||
14-Day RSI | 63.65 | |||||
3-1 Month Momentum % | 4.46 | |||||
6-1 Month Momentum % | -8.24 | |||||
12-1 Month Momentum % | 2.63 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 3.36 | |||||
Quick Ratio | 3.29 | |||||
Cash Ratio | 1.78 | |||||
Days Inventory | 9.6 | |||||
Days Sales Outstanding | 66.53 | |||||
Days Payable | 28.68 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Dividend Yield % | 2.59 | |||||
Dividend Payout Ratio | 0.57 | |||||
3-Year Dividend Growth Rate | 16 | |||||
Forward Dividend Yield % | 4.11 | |||||
5-Year Yield-on-Cost % | 4.55 | |||||
Shareholder Yield % | 2.59 |
Profitability Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 51.98 | |||||
Operating Margin % | 36.08 | |||||
Net Margin % | 29.77 | |||||
EBITDA Margin % | 41.31 | |||||
FCF Margin % | 16.83 | |||||
OCF Margin % | 27.61 | |||||
ROE % | 25.56 | |||||
ROA % | 21.57 | |||||
ROIC % | 38.78 | |||||
3-Year ROIIC % | 43.3 | |||||
ROC (Joel Greenblatt) % | 62.82 | |||||
ROCE % | 30.18 | |||||
Years of Profitability over Past 10-Year | 10 | |||||
Moat Score | 5 | |||||
Tariff Resilience Score | 7 |
GF Value Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 22.82 | |||||
Forward PE Ratio | 20.58 | |||||
PE Ratio without NRI | 22.8 | |||||
Shiller PE Ratio | 31.81 | |||||
Price-to-Owner-Earnings | 29.87 | |||||
PEG Ratio | 0.62 | |||||
PS Ratio | 6.79 | |||||
PB Ratio | 5.8 | |||||
Price-to-Tangible-Book | 6 | |||||
Price-to-Free-Cash-Flow | 40.4 | |||||
Price-to-Operating-Cash-Flow | 24.64 | |||||
EV-to-EBIT | 15.94 | |||||
EV-to-Forward-EBIT | 16.35 | |||||
EV-to-EBITDA | 14.23 | |||||
EV-to-Forward-EBITDA | 14.35 | |||||
EV-to-Revenue | 5.87 | |||||
EV-to-Forward-Revenue | 5.86 | |||||
EV-to-FCF | 34.65 | |||||
Price-to-GF-Value | 1.04 | |||||
Price-to-Projected-FCF | 1.95 | |||||
Price-to-Median-PS-Value | 0.8 | |||||
Price-to-Peter-Lynch-Fair-Value | 0.91 | |||||
Price-to-Graham-Number | 2.46 | |||||
| Price-to-Net-Current-Asset-Value | 18.89 | |||||
| Price-to-Net-Cash | 85 | |||||
Earnings Yield (Greenblatt) % | 6.27 | |||||
FCF Yield % | 2.73 | |||||
Forward Rate of Return (Yacktman) % | 23 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Bumrungrad Hospital PCL Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 682.214 | ||
| EPS (TTM) (€) | 0.235 | ||
| Beta | 0.7167 | ||
| 3-Year Sharpe Ratio | 0.04 | ||
| 3-Year Sortino Ratio | 0.05 | ||
| Volatility % | 41.17 | ||
| 14-Day RSI | 63.65 | ||
| 14-Day ATR (€) | 0.066558 | ||
| 20-Day SMA (€) | 4.855 | ||
| 12-1 Month Momentum % | 2.63 | ||
| 52-Week Range (€) | 3.64 - 5.65 | ||
| Shares Outstanding (Mil) | 794.97 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Bumrungrad Hospital PCL Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Bumrungrad Hospital PCL Stock Events
| Event | Date | Price (€) | ||
|---|---|---|---|---|
| THB 4.000000 Cash Dividend | 2026-08-28 | In 7 days | ||
| THB 3.000000 Cash Dividend | 2026-03-17 | 4.66 (+0.00%) | ||
| THB 6.000000 Cash Dividend | 2026-03-17 | 4.66 (+0.00%) | ||
| THB 2.000000 Cash Dividend | 2025-08-14 | 4.86 (+0.00%) | ||
| THB 3.000000 Cash Dividend | 2025-03-19 | 4.72 (+0.00%) | ||
| THB 2.000000 Cash Dividend | 2024-08-23 | 6.30 (+0.00%) |
Show
Entries
Bumrungrad Hospital PCL Frequently Asked Questions
What is Bumrungrad Hospital PCL(FRA:BZ7A)'s stock price today?
The current price of FRA:BZ7A is €5.10. The 52 week high of FRA:BZ7A is €5.65 and 52 week low is €3.64.
When is next earnings date of Bumrungrad Hospital PCL(FRA:BZ7A)?
The next earnings date of Bumrungrad Hospital PCL(FRA:BZ7A) is .
Does Bumrungrad Hospital PCL(FRA:BZ7A) pay dividends? If so, how much?
The Dividend Yield %  of Bumrungrad Hospital PCL(FRA:BZ7A) is 2.59% (As of Today), Highest Dividend Payout Ratio of Bumrungrad Hospital PCL(FRA:BZ7A) was 2.31. The lowest was 0.46. And the median was 0.58. The  Forward Dividend Yield % of Bumrungrad Hospital PCL(FRA:BZ7A) is 4.11%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Bumrungrad Hospital PCL
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers